Transfer addiction after gastric sleeve surgery is an important but often overlooked risk that patients and clinicians should understand before and after bariatric procedures. When food is physically restricted following a sleeve gastrectomy, some individuals may find their brain seeks alternative sources of reward — leading to new compulsive behaviours involving alcohol, gambling, or other substances. Recognised by BOMSS and addressed within NHS bariatric pathways, transfer addiction does not affect every patient, but awareness is essential for informed consent, psychological preparation, and long-term wellbeing after weight loss surgery.

What Is Transfer Addiction After Gastric Sleeve Surgery?

Transfer addiction after gastric sleeve surgery is when a patient replaces food-related compulsive behaviour with a new dependency, such as alcohol or gambling, because the surgery restricts food intake but does not address underlying psychological reward-seeking mechanisms.

Have any more questions about this? Message our pharmaceutical team to get more info →

Transfer addiction — sometimes referred to as addiction transfer or cross-addiction — is a phenomenon in which a person who has undergone bariatric surgery, such as a gastric sleeve (sleeve gastrectomy), develops a new compulsive behaviour or substance dependency following the procedure. Rather than the original compulsion being resolved, it appears to shift or 'transfer' to a different outlet. This is not a formally classified diagnosis in the DSM-5 or ICD-11, but it is a recognised clinical concern among bariatric healthcare teams in the UK and internationally, acknowledged by bodies including the British Obesity and Metabolic Surgery Society (BOMSS).

The gastric sleeve procedure involves removing approximately 75–80% of the stomach, creating a smaller, tube-shaped stomach. Whilst this significantly restricts food intake and supports substantial weight loss, it does not address the underlying psychological or neurological factors that may have contributed to disordered eating in the first place. For some patients, food has served as a primary coping mechanism — a source of comfort, reward, or emotional regulation. When that mechanism is physically restricted post-surgery, it is hypothesised that the brain may seek alternative sources of reward stimulation, though the precise mechanisms remain an area of ongoing research.

Prevalence estimates vary across studies, and it is important to emphasise that transfer addiction does not affect every patient who undergoes gastric sleeve surgery. Many individuals go on to achieve excellent long-term outcomes with appropriate support. However, awareness of this risk is a crucial part of informed consent and pre-operative psychological preparation. Understanding what transfer addiction is — and why it may occur — is the first step in preventing or managing it effectively.

Why Bariatric Surgery Can Increase Addiction Risk

Bariatric surgery may increase addiction risk by altering dopamine reward pathways, gut hormone profiles, and alcohol pharmacokinetics, while rapid weight loss can also create psychological and emotional challenges that heighten vulnerability to compulsive behaviours.

The neurobiological basis of transfer addiction following gastric sleeve surgery is hypothesised to involve the brain's reward system, particularly the mesolimbic dopamine pathway. Research suggests that some individuals with obesity may have alterations in dopamine receptor density and reward processing, potentially increasing susceptibility to compulsive behaviours, though this remains an area of active investigation and findings should be interpreted cautiously.

Physiological changes following sleeve gastrectomy may also play a role. The surgery alters gut hormone profiles, including changes to ghrelin (the 'hunger hormone'), GLP-1, and peptide YY. These hormonal shifts affect appetite and may influence mood and reward sensitivity, though the precise relationship between these hormonal changes and addictive behaviour is not yet fully established.

Alcohol pharmacokinetics are also affected by bariatric surgery. Studies have shown that alcohol is absorbed more rapidly and reaches higher peak blood alcohol concentrations after bariatric procedures, due to changes in gastric emptying and reduced first-pass metabolism. This effect appears to be more pronounced following Roux-en-Y gastric bypass (RYGB) than after sleeve gastrectomy, based on available pharmacokinetic evidence, though sleeve gastrectomy patients are not without risk. BOMSS advises all bariatric patients to be aware of increased sensitivity to alcohol post-operatively.

Psychosocial factors are equally significant. Rapid and dramatic weight loss can bring unexpected emotional challenges, including changes in identity, relationships, and self-perception. Some patients report that the social and emotional role food once played is left unfilled, creating a psychological void. Pre-existing mental health conditions — such as depression, anxiety, binge eating disorder, or a history of trauma — are known risk factors for transfer addiction and are routinely assessed during pre-operative psychological evaluation in NHS bariatric pathways, in line with NICE guidance (CG189).

Common Forms of Transfer Addiction Following Weight Loss Surgery

The most common forms include alcohol use disorder, compulsive gambling, shopping compulsions, recreational drug misuse, and excessive exercise — behaviours become clinically concerning when they are compulsive, distressing, or causing harm.

Transfer addiction can manifest in a wide variety of behaviours, and it is important to approach this topic without stigma. The most commonly reported forms following bariatric surgery include:

• Alcohol use disorder: This is one of the most extensively studied forms of transfer addiction in bariatric patients. Large cohort studies, including research published in JAMA Surgery, have found a significantly increased risk of alcohol use disorder in the years following bariatric procedures. The evidence for this risk is strongest for Roux-en-Y gastric bypass (RYGB); findings for sleeve gastrectomy are more mixed, though patients should remain vigilant given the pharmacokinetic changes described above.

• Gambling and risk-taking behaviours: Some patients develop compulsive gambling or engage in other thrill-seeking activities. If you are concerned about gambling-related harms, the NHS Problem Gambling Service and the National Gambling Support Network offer specialist support in the UK.

• Shopping and spending compulsions: Compulsive buying behaviour has been reported in some post-bariatric patients, often linked to the emotional regulation function that food previously served.

• Recreational drug use: Increased use of illicit substances or misuse of prescription medications, including opioids and benzodiazepines, has been documented in some post-operative populations.

• Excessive exercise: Whilst physical activity is encouraged after surgery, a subset of patients may develop compulsive or excessive exercise patterns that carry their own health risks.

• Relationship and sexual compulsivity: Changes in body image and confidence post-surgery can, in some cases, contribute to compulsive relationship-seeking behaviours.

It is worth noting that not all new behaviours following surgery are pathological, and some of the above (such as excessive exercise or relationship changes) are not formal clinical diagnoses. The key distinction lies in whether the behaviour is compulsive, distressing, or causing harm to the individual's health, relationships, or daily functioning.

Recognising the Signs and Seeking Support on the NHS

Key warning signs include growing preoccupation with a new behaviour, using it to cope with negative emotions, and inability to stop despite consequences; patients should contact their GP, bariatric team, or NHS 111 promptly for assessment and referral.

Recognising transfer addiction can be challenging, particularly because some new behaviours — such as increased socialising or exercise — may initially appear positive. However, there are warning signs that warrant attention and professional support. These include:

• A growing preoccupation with a new behaviour or substance

• Using the behaviour to cope with stress, anxiety, or negative emotions

• Feeling unable to stop or cut down despite wanting to

• Neglecting responsibilities, relationships, or self-care as a result

• Experiencing withdrawal-like symptoms (irritability, restlessness, low mood) when the behaviour is unavailable

• Continuing the behaviour despite negative consequences

If you or someone you know is experiencing these signs following gastric sleeve surgery, it is important to seek support promptly. In the first instance, contact your GP, who can provide an initial assessment and referral. Screening tools such as the AUDIT-C or full AUDIT questionnaire are commonly used in UK primary care to identify alcohol-related concerns. Most NHS bariatric services offer post-operative follow-up that includes psychological support, and your bariatric team should be informed of any concerns.

For alcohol-related concerns, NHS services such as alcohol liaison nurses and community alcohol teams may be appropriate. Referral to NHS Talking Therapies for anxiety and depression (formerly known as IAPT) may also be considered for underlying psychological difficulties. The NHS website (nhs.uk/live-well/alcohol-advice) and FRANK (the national drugs helpline, available at talktofrank.com) provide accessible information and signposting.

If you are in crisis or feel your safety is at risk, call 999 if there is immediate danger, contact your GP urgently, call NHS 111, reach your local NHS urgent mental health helpline (available 24 hours a day in most areas — details at nhs.uk), or attend your nearest A&E department. Early intervention significantly improves outcomes, and there is no need to wait until a problem becomes severe before seeking help.

Treatment and Psychological Support Available in the UK

CBT is the NICE-recommended first-line psychological treatment, with a stepped-care approach for alcohol use disorder that may include acamprosate, naltrexone, or disulfiram under specialist supervision in line with NICE CG115.

Treatment for transfer addiction following gastric sleeve surgery is most effective when it is tailored to the individual and addresses both the addictive behaviour and its underlying psychological drivers. In the UK, a range of evidence-based options are available through NHS and private pathways.

Psychological therapies form the cornerstone of treatment. Cognitive Behavioural Therapy (CBT) is recommended by NICE for a range of addictive and compulsive behaviours (NICE CG115) and helps patients identify and challenge the thought patterns and emotional triggers that sustain the behaviour. Other NICE-supported approaches for alcohol use disorder include behavioural couples therapy and social network and environment-based interventions. Dialectical Behaviour Therapy (DBT) — which focuses on emotional regulation, distress tolerance, and mindfulness — may be offered in some specialist settings for patients with difficulties managing intense emotions, though it is not currently a NICE-recommended treatment specifically for addictions and should be considered alongside, rather than instead of, NICE-endorsed approaches.

For alcohol use disorder specifically, NICE guidance (CG115) recommends a stepped-care approach that may include brief interventions, structured community-based treatment, and in some cases medically assisted withdrawal. Medications such as acamprosate, naltrexone, or disulfiram may be considered under specialist supervision, in line with NICE CG115 and individual BNF/SmPC guidance regarding dosing, contraindications, and monitoring. Nalmefene (NICE TA325) may also be considered for adults with alcohol dependence who have a high drinking risk level, where there is no physical withdrawal and who do not require immediate detoxification. All pharmacological treatments should be prescribed and monitored by an appropriately qualified clinician. It should be noted that the use of naltrexone for non-alcohol compulsive behaviours is off-label and supported only by limited evidence; it is not currently endorsed by NICE for this purpose.

Peer support groups — including Alcoholics Anonymous (AA), Gamblers Anonymous, and specialist bariatric support groups — can provide valuable community and accountability alongside formal treatment. Many NHS bariatric centres now incorporate pre- and post-operative psychological support as standard, recognising that long-term surgical success depends as much on mental health as on physical outcomes. In line with NICE CG189 and BOMSS standards, patients are encouraged to remain engaged with their specialist bariatric team for at least two years post-surgery, with ongoing monitoring in primary care thereafter.

Reducing Your Risk Before and After Gastric Sleeve Surgery

Engaging honestly with pre-operative psychological assessment, developing non-food coping strategies before surgery, and attending all post-operative follow-up appointments are the most effective steps to reduce transfer addiction risk.

Prevention is far preferable to treatment, and there are meaningful steps that both patients and healthcare professionals can take to reduce the risk of transfer addiction following gastric sleeve surgery. The NHS bariatric pathway typically includes a pre-operative psychological assessment, which screens for existing mental health conditions, substance use, and disordered eating patterns. Engaging honestly and openly with this process is essential — it is not a barrier to surgery, but a tool to ensure the best possible outcome.

Before surgery, consider the following:

• Engage fully with any recommended psychological therapy or counselling prior to the procedure

• Be honest with your bariatric team about your relationship with food, alcohol, or other substances — including any prescribed or over-the-counter medicines that may carry misuse potential

• Develop a toolkit of non-food coping strategies — such as mindfulness, journalling, physical activity, or talking therapies — before surgery, so they are already established post-operatively

• Discuss your personal and family history of addiction or mental health conditions with your clinical team

After surgery, ongoing vigilance is important:

• Attend all follow-up appointments with your bariatric team, including psychological reviews, for at least two years post-surgery; thereafter, annual review in primary care is recommended in line with NICE CG189 and BOMSS guidance

• Be mindful of your alcohol intake — BOMSS advises avoiding alcohol in the initial months following surgery; even small amounts may have a significantly stronger effect post-operatively due to altered absorption, and you should not drink and drive

• Seek support early if you notice new compulsive behaviours emerging, rather than waiting for them to escalate

• Maintain connection with a support network, whether through NHS services, peer support groups, or trusted individuals in your life

Ultimately, gastric sleeve surgery is a powerful tool for improving health and quality of life. With appropriate psychological preparation and ongoing support, the risk of transfer addiction can be significantly reduced, enabling patients to achieve sustainable, long-term wellbeing.

Frequently Asked Questions